{
  "pmcid": "5647649",
  "sha256": "8ad3ddfefe1359733ff5f0b1ba7685bed230fe03a27c04da20448248eba72f04",
  "timestamp_utc": "2025-11-09T16:04:58.523270+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.464897959183677,
    "reading_ease": 27.617482993197314,
    "word_count": 245
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "we conducted a randomized, phase II study"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Nineteen GIST patients undergoing surgical resection were randomized"
      },
      "Participants": {
        "score": 1,
        "evidence": "Nineteen GIST patients undergoing surgical resection"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomized to receive 3, 5, or 7 days of preoperative imatinib (600 mg daily). Patients received postoperative imatinib for 2 years."
      },
      "Objective": {
        "score": 1,
        "evidence": "to assess the safety and efficacy of preoperative and postoperative imatinib for the treatment of GIST."
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "The efficacy of imatinib was assessed by 18 fluorodeoxyglucose positron emission tomography ( 18 FDG-PET), dynamic computed tomography (dCT), terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay, and DFS."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Nineteen GIST patients undergoing surgical resection were randomized"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Median DFS of patients treated with surgery and imatinib was 46 months (range 10–46 months)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Imatinib did not affect surgical morbidity as compared with an imatinib-naïve cohort ( p ≥ 0.1)."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 11,
    "max_score": 25
  }
}